BiotechTube
PharmaIN

PharmaIN

San Diego, United States· Est.
pharmain.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

PharmaIN is a private, clinical-stage biotech based in San Diego, leveraging expertise in peptide drug design and delivery to create convenient subcutaneous therapies for serious diseases. Its lead asset, PHIN-214, is in Phase 1 for liver cirrhosis, with data presented at major liver conferences. The company is actively seeking a strategic partner to advance its pipeline and has secured over $75M in funding from a mix of NIH grants, investors, and corporate partners.

Liver CirrhosisOncology

Technology Platform

Integrated platform of target-specific biology, peptide drug design, and innovative drug delivery focused on enabling safe and effective subcutaneous administration of engineered peptide therapeutics.

Opportunities

The high unmet need in decompensated cirrhosis presents a multi-billion dollar market opportunity for a convenient, effective therapy.
Success with PHIN-214 would validate the subcutaneous peptide platform, enabling expansion into other disease areas like oncology and creating significant partnership value.

Risk Factors

The lead program is only in Phase 1, facing inherent clinical trial risks of failure in efficacy or safety.
The business model depends on securing a major strategic partnership, introducing deal execution risk.
Competition in liver disease and potential slow physician adoption of a new therapy are additional market risks.

Competitive Landscape

In liver cirrhosis, competition includes standard care (diuretics, beta-blockers), generic drugs, and a limited number of late-stage novel agents. PharmaIN's primary differentiation is its subcutaneous, potentially at-home delivery of a vasopressor therapy, aiming for superior convenience and patient quality of life compared to IV infusions or complex inpatient procedures.

More companies in Drug Delivery & Formulation →More companies in United States →